Skip to main navigation

Aura Biosciences

Main Menu

  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisors
  • VDC Platform
    • Virus-like Drug Conjugates (VDCs)
    • Publications
    • Scientific Presentations
  • Pipeline
    • Pipeline
    • Ocular Oncology
    • Choroidal Melanoma
    • Choroidal Metastases
    • Other Solid Tumors
    • Bladder Cancer
  • Investors & Media
    • Corporate Profile
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Investor Resources
  • Careers
  • Contact
SEC Filing Details

Document Details

Form
8-K
Filing Date
February 16, 2023
Document Date
February 16, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Aura Biosciences
Issuer
AURA BIOSCIENCES, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Investor Relations

  • Corporate Profile
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Investor & Media Contact

Argot Partners
aura@argotpartners.com
 

Tools

Print Page
Print Page
Email Alerts
Email Alerts
Contact IR
Contact IR

©2023 Aura Biosciences, Inc.        info@aurabiosciences.com       Privacy Policy  | Terms of Use      Site Credits

Social Media